Go to the list of all blogs
Arthur Evans's Avatar
published in Blogs
May 18, 2026
Baidu (BIDU) Q1 2026 Earnings: AI Business Fuels Growth Amid Revenue Dip

Baidu (BIDU) Q1 2026 Earnings: AI Business Fuels Growth Amid Revenue Dip

Key Takeaways

  • Revenue fell 2% QoQ to RMB 32.1 billion, missing the slight growth consensus.
  • Core AI‑powered Business revenue surged 49% YoY to RMB 13.6 billion, now 52% of total revenue.
  • Adjusted EBITDA rose to RMB 6.0 billion (19% margin) despite overall sales weakness.
  • Non‑GAAP diluted EPS (American depositary share (ADS) earnings per share) reached RMB 12.06 ($1.75), beating estimates.
  • Share repurchases returned US$172 million to investors; cash and investments sit at RMB 279.3 billion.

Earnings Context and Why It Matters

Baidu, Inc. (BIDU) released its unaudited first‑quarter 2026 results on May 18, 2026. This quarter is pivotal because the company is shifting from a search‑centric model toward an AI‑driven growth engine. Investors are watching closely as AI Cloud and autonomous‑driving ventures represent the primary levers for future margin expansion, while the traditional online‑marketing segment continues to feel pressure. The mixed performance—robust AI revenue growth against a modest overall revenue dip—offers a clear view of how sustainable Baidu’s strategic pivot might be and informs valuation multiples for both growth‑ and profit‑focused investors.

Reported Results

Total revenue declined 2% QoQ to RMB 32.1 billion ($4.65 billion). Baidu General Business revenue held steady at RMB 26.0 billion, up 2% YoY, while the Core AI‑powered Business generated RMB 13.6 billion, a 49% YoY increase and now representing 52% of total revenue.

AI Cloud Infra revenue rose 79% YoY to RMB 8.8 billion, propelled by a 184% YoY surge in GPU Cloud services. AI Applications revenue was flat YoY at RMB 2.5 billion, down 10% QoQ, and AI‑native marketing services climbed 36% YoY to RMB 2.3 billion, though they slipped 15% QoQ.

Operating income was RMB 3.2 billion (10% margin). Non‑GAAP operating income improved to RMB 3.8 billion (12% margin). Net income attributable to Baidu was RMB 3.4 billion, yielding a GAAP diluted EPS of RMB 8.76 ($1.27). Non‑GAAP diluted EPS reached RMB 12.06 ($1.75). Adjusted EBITDA stood at RMB 6.0 billion (19% margin). Operating cash flow remained positive at RMB 2.7 billion.

Share repurchases returned US$172 million to shareholders, and total cash and investments totaled RMB 279.3 billion. Apollo Go delivered 3.2 million fully driverless rides, a >120% YoY increase, while Baidu App monthly active users (MAUs) reached 655 million in March.

Market Reaction and Investor Sentiment

Even though earnings per share topped expectations, BIDU shares slipped roughly 5.5% in the immediate post‑earnings session. The decline reflects lingering concerns over the headline revenue contraction and softness in the online‑marketing segment. Analysts praised the AI‑driven growth but warned that sustaining momentum will require careful cost management in legacy businesses. Sentiment is therefore mixed: optimism for AI cloud and autonomous‑driving upside is tempered by short‑term revenue volatility.

Forward Outlook and Key Factors to Monitor

Going forward, Baidu plans to double down on AI Cloud infrastructure and scale the Apollo Go autonomous‑vehicle platform. Key catalysts include the rollout of new AI models such as ERNIE 5.1, potential partnerships for international robotaxi deployments, and the monetization of AI‑native marketing services. Investors should keep an eye on YoY growth rates in AI Cloud Infra and GPU Cloud, as well as margin trends within the Core AI‑powered Business.

Cost control will remain critical, especially as content acquisition expenses and staffing levels adjust in the legacy search and iQIYI segments. Baidu’s sizable cash balance offers flexibility for strategic investments or additional share buybacks, but any guidance revisions on revenue mix or capital allocation are likely to move the stock.

Regulatory developments in China’s internet and data‑privacy landscape could also affect Baidu’s advertising and AI deployment capabilities. Monitoring quarterly updates on MAU growth, robotaxi ride volumes, and international testing milestones will help gauge the durability of the AI‑centric growth narrative.

Using Tickeron’s AI Tools in My Research

In preparing this analysis, I leveraged Tickeron’s AI Screener to benchmark Baidu against peers in the AI and cloud space. Additionally, the AI Daily Buy/Sell Signals tool helped me spot short‑term price pressures that may have contributed to the post‑earnings dip. These AI‑driven resources streamline the research workflow and provide a data‑rich backdrop for evaluating companies like Baidu.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BIDU

Contributor

Financial writer and active order flow futures trader with a focus on fundamental analysis, macroeconomic factors, and equity research. I make in-depth blogs on stocks and ETFs, bridging the gap between raw market data and real-world trading decisions.


BIDU's RSI Indicator climbs out of oversold territory

The RSI Indicator for BIDU moved out of oversold territory on August 27, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 31 similar instances when the indicator left oversold territory. In 23 of the 31 cases the stock moved higher. This puts the odds of a move higher at 74%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 39 of 55 cases where BIDU's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.

The Moving Average Convergence Divergence (MACD) for BIDU just turned positive on September 17, 2026. Looking at past instances where BIDU's MACD turned positive, the stock continued to rise in 34 of 46 cases over the following month. The odds of a continued upward trend are 74%.

Following a +2.78% 3-day Advance, the price is estimated to grow further. Considering data from situations where BIDU advanced for three days, in 197 of 272 cases, the price rose further within the following month. The odds of a continued upward trend are 72%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BIDU as a result. In 65 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 74%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BIDU declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 76%.

BIDU broke above its upper Bollinger Band on September 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for BIDU entered a downward trend on September 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 73 (best 1 - 100 worst), indicating slightly worse than average price growth. BIDU’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.777) is normal, around the industry mean (1.386). P/E Ratio (78.194) is within average values for comparable stocks, (400.404). Projected Growth (PEG Ratio) (0.818) is also within normal values, averaging (16.810). Dividend Yield (0.000) settles around the average of (0.013) among similar stocks. P/S Ratio (1.605) is also within normal values, averaging (69.903).

The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BIDU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

Notable companies

The most notable companies in this group are Alphabet (NASDAQ:GOOGL), Alphabet (NASDAQ:GOOG), Meta Platforms (NASDAQ:META), Spotify Technology SA (NYSE:SPOT), Nebius Group N.V. (NASDAQ:NBIS), Baidu (NASDAQ:BIDU), Tencent Music Entertainment Group (NYSE:TME), Pinterest (NYSE:PINS), Snap (NYSE:SNAP), Zillow Group (NASDAQ:Z).

Industry description

Companies in this industry typically license software on a subscription basis and it is centrally hosted. Such products usually go by the names web-based software, on-demand software and hosted software. Cloud computing has emerged as a major force in this space, making it possible to save files to a remote database (without requiring them to be saved on local storage device); as long as a device has access to the web, it can access the data and the software programs to run it. This has in many cases facilitated cost efficiency, speed and security of data for businesses and consumers. Alphabet Inc., Facebook, Inc. and Yahoo! Inc. are some well-known names in the internet software/services industry.

Market Cap

The average market capitalization across the Internet Software/Services Industry is 150.01B. The market cap for tickers in the group ranges from 107 to 4.32T. GOOGL holds the highest valuation in this group at 4.32T. The lowest valued company is STBXF at 107.

High and low price notable news

The average weekly price growth across all stocks in the Internet Software/Services Industry was -2%. For the same Industry, the average monthly price growth was -7%, and the average quarterly price growth was 1%. PAAI experienced the highest price growth at 72%, while NAMI experienced the biggest fall at -48%.

Volume

The average weekly volume growth across all stocks in the Internet Software/Services Industry was 26%. For the same stocks of the Industry, the average monthly volume growth was 27% and the average quarterly volume growth was -24%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 45
P/E Growth Rating: 73
Price Growth Rating: 62
SMR Rating: 77
Profit Risk Rating: 93
Seasonality Score: -20 (-100 ... +100)
View a ticker or compare two or three
BIDU
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

an Internet search engine

Industry InternetSoftwareServices

Industry
Internet Software Or Services
Address
No. 10 Shangdi 10th Street
Phone
+86 1059928888
Employees
33500
Web
https://ir.baidu.com
Interact to see
Advertisement
INSM shares are surging approximately +10% in premarket trading on Monday, March 23, 2026, from a prior close of $136.00, placing the premarket price near $149.60. The primary catalyst is the release of positive topline results from the Phase 3 ENCORE trial of ARIKAYCE® in patients with newly diagnosed or recurrent MAC (Mycobacterium avium complex) lung disease — a readout Insmed had flagged as expected in "March or April 2026".
CF shares are trading approximately -6% lower in Monday's premarket session, dropping from a Friday close of $124.90 to approximately $117.41. Primary catalyst: President Trump announced a five-day pause on strikes against Iranian energy infrastructure following "very good" diplomatic signals, triggering a sharp unwind of the geopolitical risk premium embedded in fertilizer stocks.
APGE shares surged approximately 16% in premarket trading on March 23, 2026, after the company announced positive 52-week data from Part A of its Phase 2 APEX clinical trial. The primary catalyst is a highly anticipated clinical readout showing that zumilokibart (APG777) delivered durable and deepening responses in patients with moderate-to-severe atopic dermatitis at both every 3-month and 6-month dosing intervals.
Shares of VALN are plummeting approximately 35% in Monday's session, from a Friday close of $10.66 to roughly $6.93, in heavy volume trading. The primary catalyst is the release of Phase 3 VALOR trial topline results for Valneva's Lyme disease vaccine candidate, co-developed with PFE (Pfizer) — results that showed strong clinical efficacy but failed to meet the pre-determined statistical criterion for the primary endpoint.
AXTI is surging approximately +11.00% in Monday's session, trading near $60.21, up from a prior closing price of $54.24. The move extends the stock's post-earnings rally that began last Thursday when shares jumped more than 19% following AXT's Q4 2025 results.
Tower Semiconductor (TSEM) shares are surging approximately +10% intraday on Monday, March 23, trading around $180, up from the previous close of $163.63 on March 20, 2026. The primary catalyst is the opening day of APEC 2026 in San Antonio, Texas, where Tower Semiconductor is presenting its newly unveiled Gen3 BCD power management platform designed to address escalating AI data center power demands.
CD is indicated down about 17% in premarket trading after the latest completed session, pointing to a sharp negative market reaction heading into the open. The stock’s weakness comes against a backdrop of lingering uncertainty following its privatization and delisting process from Nasdaq, which has left limited liquidity and a thinner news flow around the name.
SEDG is indicated down roughly 9% in premarket trading, following a strong advance in the prior regular session. The pullback comes after shares rallied on optimism around new product launches and an analyst upgrade, leaving the stock vulnerable to profit-taking and volatility.
NTGR shares surged approximately 11% in premarket trading on March 24, 2026, building on a roughly 20% overnight jump in the prior session. The primary catalyst is a landmark Federal Communications Commission (FCC) ruling that prohibits all imports of consumer routers manufactured overseas, citing national security concerns.
ANNA is surging approximately +20.00% in Tuesday's premarket session, rebounding sharply from Monday's -22.84% decline. The primary catalyst remains the ongoing U.S.-Iran military conflict, which disrupted Qatari LNG exports and drove European benchmark natural gas prices to multi-year highs.
Concentrix Corporation (CNXC) shares are falling approximately 11% in Tuesday's premarket session after the company released its fiscal Q1 2026 earnings report before market open. Adjusted diluted EPS came in at $2.61, missing the Wall Street consensus estimate of approximately $2.64.
Shares of Karyopharm Therapeutics (KPTI) are trading approximately 12% lower in Tuesday's premarket session, with the previous close at $7.63. The primary catalyst is the March 24 release of topline Phase 3 SENTRY trial data, in which the company met only one of two co-primary endpoints.
IBRX shares are down approximately 23% in Tuesday's session, trading near $7.24 after closing at $9.40 on Monday, March 23. The sharp decline follows an 11%+ surge in the prior session, with profit-taking and valuation pressure cited as primary triggers.
Shares of Circle Internet Group (CRCL) are down approximately 9% in Tuesday morning trading, extending a pullback from recent multi-month highs above $126. The primary catalyst appears to be a broad crypto-sector risk-off wave, with Bitcoin sliding below $69,000 and the Fear & Greed Index dropping to extreme fear territory.
ALM shares are indicated down about 11% in early Tuesday trading after closing the prior session at $16.93. The move comes after a powerful multi‑month rally that took the stock from below $3 to an intraday high of $22.55 earlier in March, leaving it vulnerable to profit-taking and volatility.​
LUNR shares are indicated down about 7% in Tuesday premarket trading after closing the last regular session at $20.31. The pullback follows a powerful rally driven by strong 2026 revenue guidance of $900 million–$1 billion and upbeat analyst commentary, including price target hikes and buy ratings.
MAZE shares are trading approximately 27% lower in premarket on March 25, 2026, after the company reported its highly anticipated Phase 2 HORIZON trial topline data for lead drug candidate MZE829. The catalyst is a dual announcement: Phase 2 clinical data for MZE829 in APOL1-mediated kidney disease (AMKD) alongside Q4 and full-year 2025 financial results.
ARM shares surged approximately +10% in premarket trading on March 25, 2026, hitting $148.6 from a prior close of approximately $135. The primary catalyst is Arm's historic strategic pivot: the company announced it will begin selling its own self-developed AGI CPU chips, breaking its decades-long "IP licensing only" business model.
Shares of Enliven Therapeutics (ELVN) are surging approximately +15% in premarket trading on March 25, 2026, driven by renewed investor enthusiasm around the company's advancing clinical program for ELVN-001 in chronic myeloid leukemia (CML). The stock's prior closing price on March 24, 2026 was $31.15, placing the premarket indicated price near $35.82.
AVXL shares are down approximately 29% in premarket trading on Wednesday, March 25, 2026, falling to roughly $2.97 from the prior close of $4.19. The primary catalyst is Anavex's formal withdrawal of its marketing authorization application (MAA) for blarcamesine from the European Union, announced in the early hours of March 25, 2026.